Moore Capital Management »

Pacira Pharmaceuticals shares owned by Moore Capital Management

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $2.2M 55k 40.07

More positions owned by Moore Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Bank of America Corporation (BAC)
Amazon (AMZN)
Freeport-mcmoran CL B Call Option (FCX)
Ally Financial (ALLY)
Aon Shs Cl A (AON)
Spotify Technology S A SHS (SPOT)
Netflix (NFLX)

View all positions for Moore Capital Management

Top funds holding Pacira Pharmaceuticals

BlackRock
Vanguard Group
Doma Perpetual Capital Management
Dimensional Fund Advisors
Renaissance Technologies
D. E. Shaw & Co
State Street Corporation
Balyasny Asset Management
American Century Companies
Goldman Sachs Group
Geode Capital Management
Impax Asset Management Group
J. Goldman & Co
Jacobs Levy Equity Management
Charles Schwab Investment Management

View all funds holding Pacira Pharmaceuticals